I feel like this technology has not reached a critical point. The company has got to partner with big data and expand the possibilities. As a one trick pony I sense that insto are holding off coming on board.
I think management need to bring aboard a technology high profile face and bring in a R & D partner.
Ann: US FDA 510k Submitted for APAS Independence, page-26
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $23.13M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $4.463K | 234.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 950618 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 278267 | 1 |
View Market Depth
| Last trade - 13.53pm 22/11/2024 (20 minute delay) ? |
| LBT (ASX) Chart |
